secwatch.observer — SEC 8-K summary
======================================

Issuer:     Liquidia Corp (LQDA)
CIK:        0001819576
Form:       8-K
Filed at:   2025-06-24T23:59:59+00:00
Accession:  0001104659-25-061835
Event type: debt
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Liquidia receives $50M from HCR after first commercial YUTREPIA sale and court win
--------------------------------------------------------------------------------

- Received $50M from HCR after court denied preliminary injunction and first commercial sale of YUTREPIA.
- Total funding under HCR agreement now $175M of $200M potential; $25M more available if net sales exceed $100M by June 30, 2026.
- Payments to HCR capped at 175% of amounts funded; true-up due if IRR falls below 13% for this $50M tranche.
- CFO says proceeds will accelerate launch execution, clinical pipeline, and manufacturing build-out.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819576/000110465925061835/0001104659-25-061835-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819576/000110465925061835/tm2518664d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-061835

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer